ASH 2011 Multiple Myeloma Update – Day One The Myeloma Beacon The second is maintenance therapy, which is longer-term therapy that patients often receive after induction therapy and (usually) a stem cell transplant. Dr. Reece explained that a large number of clinical trials have shown that the most effective ... Onyx Pharmaceuticals Provides Update on Carfilzomib at 53rd American Society ... |
